États-Unis · Bourse & Finance · Quartz

Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion

Publié par Quartz · États-Unis il y a 1 h

Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan

Lire l'article complet sur Quartz Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (qz.com)

À lire aussi

Boomers are buying into the promise of monthly income from options ETFs, but there's a tax catch

Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review

Total Energy plans share buyback

Business Insider

Barbara Palvin says she doesn't want praise for walking the Victoria's Secret fashion show 6 weeks postpartum

Elon Musk Says He Will Give a SpaceX Share to ‘Every Kid in America’

Morning Minute: Crypto Rebounds as 'Black Monday' Looms